investment & stocks ideas
investment & stocks ideas
Favourites   Have ideas?  Sign in / Register

Positive:   Food ↓6.58   Life Sciences ↓6.58   Equipment ↓6.58 «See more»   Women Health 0.00   Biopharma ↑0.03   Skin ↑1.1

Disease: Infectious stock segment: trending tickers

ARDS Aridis Pharmaceuticals Inc. - Common Stock 0 + Disease: Infectious, Pharmaceutical , Medicine
+ My List
ASMB Assembly Biosciences, Inc. - Common Stock 0.2% 0.2% 0 + Disease: Infectious, Medicine, Biopharma

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1426800/000095017025042660/0000950170-25-042660-index.htm
8-K - ASSEMBLY BIOSCIENCES, INC. (0001426800) (Filer)
+ My List
CDTX Cidara Therapeutics, Inc. - Common Stock 1.3% 1.3% 0 + Disease: Infectious, Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1610618/000161061825000018/0001610618-25-000018-index.htm
8-K - Cidara Therapeutics, Inc. (0001610618) (Filer)
+ My List
EVFM Evofem Biosciences, Inc. - Common Stock 0.00% 0 + Women Health, Disease: Infectious, Reproductive health

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1618835/000164117225004599/0001641172-25-004599-index.htm
8-K - Evofem Biosciences, Inc. (0001618835) (Filer)
+ My List
FBRX Forte Biosciences, Inc. - Common Stock 1.1% 1.1% 0 + Skin, Medicine, Disease: Infectious, Biopharma

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1419041/000119312525085762/0001193125-25-085762-index.htm
8-K - Forte Biosciences, Inc. (0001419041) (Filer)
+ My List
HOOK HOOKIPA Pharma Inc. - Common Stock 0.00% 0 + Disease: Infectious, Immunology, Cancer fight, Medicine

Last highlighted: 10-K Sec report https://www.sec.gov/Archives/edgar/data/1760542/000155837025001853/0001558370-25-001853-index.htm
10-K - HOOKIPA Pharma Inc. (0001760542) (Filer)
+ My List
ITRM Iterum Therapeutics plc - Ordinary Share 2.86% 2.86% 0 + Pharmaceutical , Medicine, Disease: Infectious

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1659323/000095017025035943/0000950170-25-035943-index.htm
8-K - Iterum Therapeutics plc (0001659323) (Filer)
+ My List
MBRX Moleculin Biotech, Inc. - Common Stock -4.35% -4.35% 0 + Biotechnology, Pharmaceutical , Medicine, Cancer fight, Disease: Infectious

Last highlighted: 10-K Sec report https://www.sec.gov/Archives/edgar/data/1659617/000143774925012375/0001437749-25-012375-index.htm
10-K/A - Moleculin Biotech, Inc. (0001659617) (Filer)
+ My List
NVAX Novavax, Inc. - Common Stock -2.9% -2.9% 0 + Covid (fighting), Medicine, Disease: Infectious

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1000694/000110465925031099/0001104659-25-031099-index.htm
8-K - NOVAVAX INC (0001000694) (Filer)
+ My List
QDEL Quidel Corporation - Common Stock -0.28% -0.28% 0 + Medicine, Disease: Infectious, Immunology
+ My List
QTRX Quanterix Corporation - Common Stock -0.19% -0.19% 0 + Healthcare, Biology, Disease: Infectious, Disease: Cardiovascular, Cancer fight, Disease: Oncology

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1503274/000150327425000042/0001503274-25-000042-index.htm
8-K - Quanterix Corp (0001503274) (Filer)
+ My List
SPRO Spero Therapeutics, Inc. - Common Stock 1.35% 1.35% 0 + Disease: Infectious, Biopharma, Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1701108/000119312525065633/0001193125-25-065633-index.htm
8-K - Spero Therapeutics, Inc. (0001701108) (Filer)
+ My List
TOMZ TOMI Environmental Solutions, Inc. - Common Stock -6.58% -6.58% 0 + Disease: Infectious, Medicine, Equipment, Life Sciences, Food, Covid (fighting)

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/314227/000165495425004236/0001654954-25-004236-index.htm
8-K - TOMI Environmental Solutions, Inc. (0000314227) (Filer)
+ My List
ESLA Estrella Immunopharma, Inc. - Common Stock -2.53% -2.53% 0 + Biopharma, Cancer fight, Disease: Infectious
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.